TABLE 3.
Factors predictive of overall, disease-specific, and recurrence-free survival.
| OS | DSS | RFS | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
||||||||||
| Univariate analysis |
Multivariate analysis | Univariate analysis |
Multivariate analysis | Univariate analysis |
Multivariate analysis | |||||||
|
|
|
|
|
|
|
|||||||
| Variables | 5-y OS (%) |
p
value |
RR (95) CI) |
p
value |
5-y DSS (%) |
p
value |
RR (95) CI) |
p
value |
5-y RFS (%) |
p
value |
RR (95) CI) |
p
value |
| Age, y | ||||||||||||
| <60 | 76 | Referent | 88 | 85 | ||||||||
| >60 | 39 | .0001 | 1.8 (0.8–3.8) | .15 | 60 | .056 | – | 67 | .07 | – | ||
| Sex | ||||||||||||
| Male | 72 | 86 | 71 | |||||||||
| Female | 49 | .04 | – | 69 | .065 | – | 83 | .52 | – | |||
| Smoking | ||||||||||||
| Never | 69 | 83 | 83 | |||||||||
| Ever | 65 | .73 | – | 84 | .25 | – | 82 | .63 | – | |||
| Alcohol | ||||||||||||
| Never | 88 | 100 | 100 | |||||||||
| Ever | 58 | .15 | – | 77 | .12 | – | 75 | .15 | – | |||
| Clinical T classification | ||||||||||||
| cT1 | 76 | 100 | 100 | |||||||||
| cT2 | 78 | 83 | 83 | |||||||||
| cT3 | 59 | 75 | 68 | |||||||||
| cT4 | 38 | .02 | – | 58 | .108 | – | 66 | .05 | – | |||
| Clinical N classification | ||||||||||||
| cN0 | 61 | 77 | 78 | |||||||||
| cN1 | 60 | 75 | 72 | |||||||||
| cN2 | 70 | 87 | 85 | |||||||||
| cN3 | 0 | .54 | – | 100 | .62 | – | 100 | .78 | – | |||
| Pathologic T classification | ||||||||||||
| pT1 | 81 | Referent | 92 | – | 88 | |||||||
| pT2 | 70 | 1.5 (0.6–3.5) | .4 | 78 | 79 | |||||||
| pT3 | 40 | 3.2 (0.8–12.9) | .09 | 50 | 50 | |||||||
| pT4 | 37 | .006 | 2.5 (0.9–6.8) | .07 | 69 | .36 | – | 75 | .13 | – | ||
| Pathologic N classification | ||||||||||||
| pN0 | 60 | 80 | 75 | |||||||||
| pN1 | 73 | 82 | 81 | |||||||||
| pN2 | 66 | .93 | – | 83 | .822 | – | 81 | .8 | – | |||
| Grade | ||||||||||||
| Well differentiated | 67 | 100 | 100 | |||||||||
| Moderately differentiated | 57 | 81 | 79 | |||||||||
| Poorly differentiated | 74 | .88 | – | 84 | .46 | – | 82 | .86 | – | |||
| Margin status | ||||||||||||
| Negative | 78 | Referent | 89 | 83 | ||||||||
| Close/positive | 52 | .01 | 1.5 (0.7–3.2) | .27 | 72 | .07 | – | 74 | .32 | – | ||
| Necrosis | ||||||||||||
| Present | 62 | 72 | 75 | |||||||||
| Absent | 66 | .76 | – | 83 | .42 | – | 81 | .08 | – | |||
| LVI | ||||||||||||
| Present | 23 | 2.4 (1–5.4) | .04 | 43 | 6.9 (1.9–25.3) | .003 | 37 | 5.5 (1.9–16.1) | .002 | |||
| Absent | 73 | .0001 | Referent | 89 | .0001 | Referent | 88 | .0001 | Referent | |||
| PNI | ||||||||||||
| Present | 50 | 71 | 83 | 1.5 (0.5–4.7) | .46 | |||||||
| Absent | 68 | .22 | – | 83 | .25 | – | 83 | .07 | Referent | |||
| ECS (n 5 68) | ||||||||||||
| Positive | 51 | 69 | 2.7 (0.7–11.2) | .16 | 71 | |||||||
| Negative | 79 | .2 | – | 93 | .03 | Referent | 90 | .15 | – | |||
| ECS, all | ||||||||||||
| Positive | 51 | 89 | 71 | |||||||||
| Negative | 72 | .3 | – | 88 | .05 | – | 85 | .28 | – | |||
| p16 status | ||||||||||||
| Positive | 74 | 89 | 87 | |||||||||
| Negative | 47 | .04 | – | 66 | .08 | 73 | .48 | |||||
Abbreviations: OS, overall survival; DSS, disease-specific survival; RFS, recurrence-free survival; RR, risk ratio; CI, confidence interval; LVI, lymphovascular invasion; PNI, perineural invasion; ECS, extracapsular spread.
The figures in bold indicate statistical significance.